Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 26, 2008. The report serves as a notification of a major shareholder interest change rather than a financial performance update.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding share ownership thresholds and does not contain financial statements.
Material Changes
The material change reported is the acquisition of voting rights by Legal & General Group plc and its subsidiaries. On August 21, 2008, the group crossed the 5% voting rights threshold in GlaxoSmithKline plc Ordinary shares.
- Shareholder: Legal & General Group plc (Group) and Legal & General Investment Management Limited (LGIM).
- Total Voting Rights: 261,984,775 shares.
- Percentage of Voting Rights: 5.00%.
- Previous Position: Below 5% (specifically 4.6606% direct and 0.3399% indirect).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly a compliance notification under DTR 5.8.12 regarding the notification of interests in shares.
Investor Verification Checklist
- Verify the total number of voting rights held by Legal & General Group plc (261,984,775) against the total issued share capital (5,238,275,257).
- Confirm the breakdown of direct versus indirect holdings within the Legal & General group structure.
- Check subsequent filings to determine if the 5% threshold was crossed again or if the position was reduced.
- Review the company's latest Form 20-F for actual financial performance metrics, as this 6-K contains none.